Benefits Of Outsourcing Of Medicine In Indian Pharmaceutical Industry

Abstract

Forecasts indicate that by 2025, India's pharmaceutical market would be worth $100 billion. 1 India's pharmaceutical exports were worth $16.3 billion in fiscal year 2019/2020. As of 2019, the Indian biotechnology market was valued at $64 billion, and by 2025, that number is expected to grow to $150 billion. Generic pharmaceutical production and export constitute the majority of the industry. After modifications to the Indian patent system in 2005 made it possible to patent pharmaceutical items, the focus shifted to the development of novel medications. Slower growth in the U.S. market is only one of these factors, alongside a decrease in the discovery, development, and commercialization of new chemical entities despite an increase in the number of blockbuster medications, competition from generic pharmaceutical goods, and regulatory obstacles. The commercial components of the sector are the primary focus of this research, which also suggests some changes to the existing business model and future directions.